Home » Topics » BioWorld Science

BioWorld Science
RSS

OncoRx gets new identity: Vion Pharmaceuticals

May 3, 1996

Sandoz to acquire Imutran

May 3, 1996

Bristol-Myers Squibb opens R&D office in Russia

May 3, 1996

Hafslund Nycomed demerger imminent

May 3, 1996

Gensia coagulation monitoring system enters phase I

May 3, 1996

Stealth liposomes possess prolonged stability

May 3, 1996

Cadus/Solvay yeast-based drug discovery program receives boost from EC

May 3, 1996

Drug discovery agreement reached by CombiChem and Teijin

May 3, 1996

Anaderm Research formed to develop skin and hair therapeutics

May 3, 1996

Novel sertraline composition for mood disorders

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...